FDA Orange Book
Is there a generic for Triumeq Pd?
Triumeq Pd contains abacavir, dolutegravir and lamivudine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Triumeq Pd (abacavir, dolutegravir and lamivudine). The Orange Book shows its last listed patent expires June 8, 2030 and its last listed exclusivity ends December 15, 2026.
Run it in Rivvi
Map Triumeq Pd and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Triumeq Pd products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, for suspension, oral | EQ 60MG BASE;EQ 5MG BASE;30MG | Marketed (Rx) | None | 0 | None |
NDA 215413, held by VIIV HEALTHCARE CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Triumeq Pd patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8129385 | October 5, 2027 | Drug substance, Drug product | None | 215413 |
| 8129385*PED | April 5, 2028 | Method of use | None | 215413 |
| 9242986 | December 8, 2029 | Drug substance, Drug product | None | 215413 |
| 9242986*PED | June 8, 2030 | Method of use | None | 215413 |
Triumeq Pd exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NPP | New patient population | June 15, 2026 | 215413 |
| PED | Pediatric exclusivity | December 15, 2026 | 215413 |
Questions
Is there a generic for Triumeq Pd?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Triumeq Pd (abacavir, dolutegravir and lamivudine). The Orange Book shows its last listed patent expires June 8, 2030 and its last listed exclusivity ends December 15, 2026.
What is the generic name for Triumeq Pd?
The active ingredient in Triumeq Pd is abacavir, dolutegravir and lamivudine, per the FDA Orange Book.
When does the Triumeq Pd patent expire?
The last patent listed for Triumeq Pd in the Orange Book expires June 8, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.